Here are the four latest drugs approved by the Food and Drug Administration this week.
1. Prevymis is an antiviral drug used to prevent cytomegalovirus infections in patients after a stem cell transplant.
2. Vyzulta is a once-daily treatment to lower intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
3. Zelboraf is the first approved treatment for Erdheim-Chester disease, a rare form of blood cancer.
4. Alecensa may now be used as an initial treatment for patients with a rare form of non-small-cell lung cancer.
More articles on supply chain:
6 medical groups to Congress: We need a 'comprehensive strategy' for critical drug shortages
AHA urges FDA to address saline bag shortage
5 recent pharma layoffs